TREATMENT OF MULTIPLE SCLEROSIS USING THE COMBINATION OF LACHINIMODA AND INTERFERON-β

• 1. 用于治疗多发性硬化症的拉喹莫德联合治疗 [P] . 中国专利： CN105848653A . 2016-08-10
• 2. 用拉喹莫德与干扰素-β的组合治疗多发性硬化症 [P] . 中国专利： CN103781355A . 2014-05-07
• 3. TREATMENT OF MULTIPLE SCLEROSIS BY COMBINATION OF LACHINIMODA AND FINGOLIMODA [P] . EA201490748A1 . 2014-12-30

  机译： 衣原体和芬戈莫达联合治疗多发性硬化症

• 4. ESTROGEN COMBINATION FOR TREATMENT OF MULTIPLE SCLEROSIS [P] . US2021137943A1 . 2021-05-13

  机译： 用于治疗多发性硬化症的雌激素组合

• 5. COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS [P] . KR20210147083A . 2021-12-06

  机译： 组合治疗治疗多发性硬化症

• 1. Role of CD20+ T cells in multiple sclerosis: implications for treatment with ocrelizumab [J] . Stefan Gingele, Thomas Skripuletz, Roland Jacobs 中国神经再生研究（英文版） . 2020,第004期
• 2. Environmental enrichment as a promising strategy for aiding multiple sclerosis treatment [J] . Berenice Anabel Silva, Carina Cintia Ferrari 中国神经再生研究（英文版） . 2020,第009期
• 3. On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system [J] . Megha Meena, Nathalie Cools 中国神经再生研究（英文版） . 2019,第012期
• 4. Reduced effectiveness of long-term interferon-{beta} treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study. [J] . Boz C, Oger J, Gibbs E, Multiple sclerosis: clinical and laboratory research . 2007,第9期
• 5. Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis [J] . Simon Zhornitsky, Trina A Johnson, Luanne M Metz, Journal of neuroinflammation . 2015,第3期
• 6. Monitoring of Lymphocyte Populations During Treatment with Interferon-β-1b to Predict Multiple Sclerosis Disability Progression [J] . Martin Vali?, Old?ich Vy?ata, Lulá? Sobí?ek, Journal of interferon and cytokine research: The official journal of the International Society for Interferon and Cytokine Research . 2019,第3期
• 7. Using a Combination of Artificial Neural Networks for the Diagnosis of Multiple Sclerosis [C] . Angel GUTIERREZ, Carlos FERNANDEZ GARCiA World multi-conference on systemics, cybernetics and informatics;WMSCI 2011 . 2012
• 8. Imaging Informatics-Based Electronic Patient Record and Analysis System for Multiple Sclerosis Research, Treatment, and Disease Tracking [D] . Ma, Kevin C. 2018
• 9. Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis [O] . Lars Börnsen, Jeppe Romme Christensen, Rikke Ratzer, -1
• 10. Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis. [O] . Lars Börnsen, Jeppe Romme Christensen, Rikke Ratzer, 2015

• 1. Interferon-γ mRNA attenuates its own translation by activating PKR： A molecular basis for the therapeutic effect of interferon-β in multiple sclerosis [J] . Raymond Kaempfer . 细胞研究：英文版 . 2006,第2期
• 2. High-dose interferon-α2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-a monotherapy [J] . Holger G. Hass ,Christian Kreysel ,Johannes Fischinger . 世界胃肠病学杂志：英文版 . 2005,第34期
• 3. 辛伐他汀与阿司匹林联合治疗老年人慢性下肢闭塞性动脉硬化症 [C] . 胡伟 ,陶连方 ,谢辉 . 湖北省微循环学会第三届会员代表大会暨第八次学术年会、武汉微循环学会第六届会员代表大会暨第十二次学术年会 . 2008
• 4. 干扰素-α和索拉菲尼联合治疗肝癌及RACK1对干扰素-α信号通路调控的研究 [A] . 王莉静 . 2012